Laboratory and clinical aspects of human herpesvirus 6 infections

Clinical Microbiology Reviews

Volumn 28, Issue 2, 2015, Pages 313-335

  Agut, Henri ^a,b,c   Bonnafous, Pascale ^a,b   Gautheret Dejean, Agnès ^a,b,c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b Assistance publique Hôpitaux de Paris   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 7 [(1,3 DIHYDROXY 2 PROPOXY) METHYL] PURINE; ALPHA INTERFERON; ARTESUNATE; BRINCIDOFOVIR; CIDOFOVIR; CYCLOPROPAVIR; DNA POLYMERASE; FOSCARNET; GANCICLOVIR; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 2; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; OMACICLOVIR; PHOSPHOTRANSFERASE; RIBONUCLEOTIDE REDUCTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URACIL DNA GLYCOSIDASE; VIRUS DNA; ANTIVIRUS AGENT;

ARTICLE; BODY FLUID; CELL FUNCTION; CLINICAL TRIAL (TOPIC); GENE EXPRESSION; GENETIC VARIABILITY; HERPES VIRUS 6 INFECTION; HERPES VIRUS INFECTION; HOST PARASITE INTERACTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNE SYSTEM; LATENT VIRUS INFECTION; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; VIRAL TROPISM; VIRUS DIAGNOSIS; VIRUS GENOME; VIRUS LATENCY; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS VIRULENCE; BLOOD; GENETICS; PATHOLOGY; ROSEOLOVIRUS INFECTIONS; VIROLOGY;

HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6;

ANTIVIRAL AGENTS; DNA, VIRAL; HERPESVIRUS 6, HUMAN; HUMANS; ROSEOLOVIRUS INFECTIONS;

EID: 84926060837     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00122-14     Document Type: Article

References (227)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601. http://dx.doi.org/10.1126/science .2876520.
2. Pellett PE, Black JB, Yamamoto M. 1992. Human herpesvirus 6: the virus and the search for its role as a human pathogen. Adv Virus Res 41:1-52. http://dx.doi.org/10.1016/S0065-3527(08)60034-2.
3. De Bolle L, Naesens L, De Clercq E. 2005. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18: 217-245. http://dx.doi.org/10.1128/CMR.18.1.217-245.2005.
4. Flamand L, Komaroff AL, Arbuckle JH, Medveczky PG, Ablashi DV. 2010. Human herpesvirus-6-basic biology, diagnostic testing, and antiviral efficacy. J Med Virol 82:1560-1568. http://dx.doi.org/10.1002 /jmv.21839.
5. Braun DK, Dominguez G, Pellett PE. 1997. Human herpesvirus 6. Clin Microbiol Rev 10:521-567.
6. Yao K, Crawford JR, Komaroff AL, Ablashi DV, Jacobson S. 2010. Human herpesvirus-6 in central nervous system diseases. J Med Virol 82:1669-1678. http://dx.doi.org/10.1002/jmv.21861.
7. Ablashi DV, Devin CL, Yoshikawa T, Lautenschlager I, Luppi M, Kuhl U, Komaroff AL. 2010. Human herpesvirus-6 in multiple nonneurological diseases. J Med Virol 82:1903-1910. http://dx.doi.org/10 .1002/jmv.21860.
8. Yamanishi K, Mori Y, Pellett PE. 2013. Human herpesviruses 6 and 7, p 2058-2079. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
9. Zerr DM. 2006. Human herpesvirus 6: a clinical update. Herpes 13:20-24.
10. Broccolo F. 2014. HHV-6A and HHV-6B in autoimmune disease, p 167-178. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
11. Agut H. 2011. Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections. J Clin Virol 52:164-171. http://dx.doi.org /10.1016/j.jcv.2011.06.008.
12. Biberfeld P, Kramarsky B, Salahuddin SZ, Gallo RC. 1987. Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease. J Natl Cancer Inst 79:933-941.
13. Josephs SF, Salahuddin SZ, Ablashi DV, Schachter F, Wong-Staal F, Gallo RC. 1986. Genomic analysis of the human B-lymphotropic virus (HBLV). Science 234:601-603. http://dx.doi.org/10.1126/science.3020691.
14. Ablashi DV, Salahuddin SZ, Josephs SF, Imam F, Lusso P, Gallo RC, Hung C, Lemp J, Markham PD. 1987. HBLV (or HHV-6) in human cell lines. Nature 329:207. http://dx.doi.org/10.1038/329207a0.
15. Frenkel N, Schirmer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich RM, June CH. 1990. Isolation of a new herpesvirus from human CD4+ T cells. Proc Natl Acad Sci U S A 87:748-752. http://dx.doi.org /10.1073/pnas.87.2.748.
16. Downing RG, Sewankambo N, Serwadda D, Honess R, Crawford D, Jarrett R, Griffin BE. 1987. Isolation of human lymphotropic herpesviruses from Uganda. Lancet ii:390.
17. Tedder RS, Briggs M, Cameron CH, Honess R, Robertson D, Whittle H. 1987. A novel lymphotropic herpesvirus. Lancet ii:390-392.
18. Agut H, Guetard D, Collandre H, Dauguet C, Montagnier L, Miclea JM, Baurmann H, Gessain A. 1988. Concomitant infection by human herpesvirus 6, HTLV-I, and HIV-2. Lancet i:712.
19. Lopez C, Pellett P, Stewart J, Goldsmith C, Sanderlin K, Black J, Warfield D, Feorino P. 1988. Characteristics of human herpesvirus-6. J Infect Dis 157:1271-1273. http://dx.doi.org/10.1093/infdis/157.6.1271.
20. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i:1065-1067.
21. Ablashi D, Agut H, Berneman Z, Campadelli-Fiume G, Carrigan D, Ceccerini-Nelli L, Chandran B, Chou S, Collandre H, Cone R, Dambaugh T, Dewhurst S, DiLuca D, Foa-Tomasi L, Fleckenstein B, Frenkel N, Gallo RC, Gompels UA, Hall C, Jones M, Lawrence G, Martin M, Montagnier L, Neipel F, Nicholas J, Pellett PE, Razzaque A, Torrelli G, Thomson B, Salahuddin SZ, Wyatt L, Yamanishi K. 1993. Human herpesvirus-6 strain groups: a nomenclature. Arch Virol 129: 363-366. http://dx.doi.org/10.1007/BF01316913.
22. Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, Diluca D, Flamand L, Frenkel N, Gallo R, Gompels UA, Hollsberg P, Jacobson S, Luppi M, Lusso P, Malnati M, Medveczky P, Mori Y, Pellett PE, Pritchett JC, Yamanishi K, Yoshikawa T. 2014. Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol 159:863-870. http: //dx.doi.org/10.1007/s00705-013-1902-5.
23. Arbuckle JH, Medveczky MM, Luka J, Hadley SH, Luegmayr A, Ablashi D, Lund TC, Tolar J, De Meirleir K, Montoya JG, Komaroff AL, Ambros PF, Medveczky PG. 2010. The latent human herpesvirus- 6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc Natl Acad Sci U S A 107:5563-5568. http://dx.doi.org/10.1073/pnas.0913586107.
24. Arbuckle JH, Pantry SN, Medveczky MM, Prichett J, Loomis KS, Ablashi D, Medveczky PG. 2013. Mapping the telomere integrated genome of human herpesvirus 6A and 6B. Virology 442:3-11. http://dx .doi.org/10.1016/j.virol.2013.03.030.
25. Kaufer BB, Flamand L. 2014. Chromosomally integrated HHV-6: impact on virus, cell and organismal biology. Curr Opin Virol 9:111-118. http://dx.doi.org/10.1016/j.coviro.2014.09.010.
26. Gompels UA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin ME, Efstathiou S, Craxton M, Macaulay HA. 1995. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209:29-51. http://dx.doi.org/10.1006/viro.1995.1228.
27. Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE. 1999. Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol 73:8040-8052.
28. Isegawa Y, Mukai T, Nakano K, Kagawa M, Chen J, Mori Y, Sunagawa T, Kawanishi K, Sashihara J, Hata A, Zou P, Kosuge H, Yamanishi K. 1999. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 73:8053-8063.
29. Achour A, Malet I, Le Gal F, Dehee A, Gautheret-Dejean A, Bonnafous P, Agut H. 2008. Variability of gB and gH genes of human herpesvirus-6 among clinical specimens. J Med Virol 80:1211-1221. http://dx.doi.org /10.1002/jmv.21205.
30. Gravel A, Gosselin J, Flamand L. 2002. Human herpesvirus 6 immediate- early 1 protein is a sumoylated nuclear phosphoprotein colocalizing with promyelocytic leukemia protein-associated nuclear bodies. J Biol Chem 277:19679-19687. http://dx.doi.org/10.1074/jbc.M200836200.
31. Rapp JC, Krug LT, Inoue N, Dambaugh TR, Pellett PE. 2000. U94, the human herpesvirus 6 homolog of the parvovirus nonstructural gene, is highly conserved among isolates and is expressed at low mRNA levels as a spliced transcript. Virology 268:504-516. http://dx.doi.org/10.1006 /viro.1999.0163.
32. Tweedy J, Spyrou MA, Hubacek P, Kuhl U, Lassner D, Gompels UA. 2015. Analyses of germline, chromosomally integrated human herpesvirus 6A and B genomes indicate emergent infection and new inflammatory mediators. J Gen Virol 96:370-389. http://dx.doi.org/10.1099/vir.0 .068536-0.
33. Stanton R, Wilkinson GW, Fox JD. 2003. Analysis of human herpesvirus- 6 IE1 sequence variation in clinical samples. J Med Virol 71:578-584. http://dx.doi.org/10.1002/jmv.10508.
34. Yamanishi K, Mori Y, Pellett PE. 2007. Human herpesviruses 6 and 7, p 2819-2845. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
35. Gravel A, Hall CB, Flamand L. 2013. Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus. J Infect Dis 207:1585-1589. http://dx.doi.org/10.1093/infdis/jit060.
36. Achour A, Malet I, Deback C, Bonnafous P, Boutolleau D, Gautheret- Dejean A, Agut H. 2009. Length variability of telomeric repeat sequences of human herpesvirus 6 DNA. J Virol Methods 159:127-130. http://dx.doi.org/10.1016/j.jviromet.2009.03.002.
37. Kato Y, Ihira M, Umeda M, Higashimoto Y, Kawamura Y, Ohashi M, Ishi J, Yoshikawa T. 2014. Copy numbers of telomeric repeat sequences of human herpesvirus 6B in clinical isolates: possibility of mixed infections. J Clin Microbiol 52:419 - 424. http://dx.doi.org/10 .1128/JCM.02192-13.
38. Lindquester GJ, Pellett PE. 1991. Properties of the human herpesvirus 6 strain Z29 genome: G+C content, length, and presence of variablelength directly repeated terminal sequence elements. Virology 182:102-110. http://dx.doi.org/10.1016/0042-6822(91)90653-S.
39. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. 1999. CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817-827. http://dx.doi.org/10.1016/S0092-8674(00)81678-5.
40. Tang H, Serada S, Kawabata A, Ota M, Hayashi E, Naka T, Yamanishi K, Mori Y. 2013. CD134 is a cellular receptor specific for human herpesvirus- 6B entry. Proc Natl Acad Sci U S A 110:9096-9099. http://dx .doi.org/10.1073/pnas.1305187110.
41. Cattaneo R. 2004. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol 78:4385-4388. http://dx.doi.org/10.1128/JVI.78.9.4385-4388.2004.
42. Donati D, Akhyani N, Fogdell-Hahn A, Cermelli C, Cassiani-Ingoni R, Vortmeyer A, Heiss JD, Cogen P, Gaillard WD, Sato S, Theodore WH, Jacobson S. 2003. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 61:1405-1411. http: //dx.doi.org/10.1212/01.WNL.0000094357.10782.F9.
43. Roush KS, Domiati-Saad RK, Margraf LR, Krisher K, Scheuermann RH, Rogers BB, Dawson DB. 2001. Prevalence and cellular reservoir of latent human herpesvirus 6 in tonsillar lymphoid tissue.AmJ Clin Pathol 116:648-654. http://dx.doi.org/10.1309/Y2HH-B1CK-0F5L-U7B8.
44. Fox JD, Briggs M, Ward PA, Tedder RS. 1990. Human herpesvirus 6 in salivary glands. Lancet 336:590-593. http://dx.doi.org/10.1016/0140 -6736(90)93392-3.
45. Okuno T, Higashi K, Shiraki K, Yamanishi K, Takahashi M, Kokado Y, Ishibashi M, Takahara S, Sonoda T, Tanaka K. 1990. Human herpesvirus 6 infection in renal transplantation. Transplantation 49: 519-522. http://dx.doi.org/10.1097/00007890-199003000-00009.
46. Harma M, Hockerstedt K, Lautenschlager I. 2003. Human herpesvirus- 6 and acute liver failure. Transplantation 76:536-539. http://dx.doi .org/10.1097/01.TP.0000069233.13409.DF.
47. Caruso A, Rotola A, Comar M, Favilli F, Galvan M, Tosetti M, Campello C, Caselli E, Alessandri G, Grassi M, Garrafa E, Cassai E, Di Luca D. 2002. HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J Med Virol 67:528-533. http://dx.doi.org/10.1002/jmv.10133.
48. Kondo K, Kondo T, Okuno T, Takahashi M, Yamanishi K. 1991. Latent human herpesvirus 6 infection of human monocytes/ macrophages. J Gen Virol 72:1401-1408. http://dx.doi.org/10.1099/0022 -1317-72-6-1401.
49. Luppi M, Barozzi P, Maiorana A, Marasca R, Torelli G. 1994. Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis 169: 943-944. http://dx.doi.org/10.1093/infdis/169.4.943.
50. Luppi M, Barozzi P, Morris C, Maiorana A, Garber R, Bonacorsi G, Donelli A, Marasca R, Tabilio A, Torelli G. 1999. Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J Virol 73:754- 759.
51. Andre-Garnier E, Milpied N, Boutolleau D, Saiagh S, Billaudel S, Imbert-Marcille BM. 2004. Reactivation of human herpesvirus 6 during ex vivo expansion of circulating CD34+haematopoietic stem cells. J Gen Virol 85:3333-3336. http://dx.doi.org/10.1099/vir.0.80319-0.
52. Lusso P, Secchiero P, Crowley RW. 1994. In vitro susceptibility of Macaca nemestrina to human herpesvirus 6: a potential animal model of coinfection with primate immunodeficiency viruses. AIDS Res Hum Retroviruses 10:181-187. http://dx.doi.org/10.1089/aid.1994.10.181.
53. Yalcin S, Mukai T, Kondo K, Ami Y, Okawa T, Kojima A, Kurata T, Yamanishi K. 1992. Experimental infection of cynomolgus and African green monkeys with human herpesvirus 6. J Gen Virol 73:1673-1677. http://dx.doi.org/10.1099/0022-1317-73-7-1673.
54. Reynaud JM, Jegou JF, Welsch JC, Horvat B. 2014. Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9. J Virol 88:5421-5436. http://dx.doi.org/10.1128/JVI.03763-13.
55. Horvat B, Berges BK, Lusso P. 2014. Recent developments in animal models for human herpesvirus 6A and 6B. Curr Opin Virol 9:97-103. http://dx.doi.org/10.1016/j.coviro.2014.09.012.
56. Schiewe U, Neipel F, Schreiner D, Fleckenstein B. 1994. Structure and transcription of an immediate-early region in the human herpesvirus 6 genome. J Virol 68:2978-2985.
57. Tsao EH, Kellam P, Sin CS, Rasaiyaah J, Griffiths PD, Clark DA. 2009. Microarray-based determination of the lytic cascade of human herpesvirus 6B. J Gen Virol 90:2581-2591. http://dx.doi.org/10.1099 /vir.0.012815-0.
58. Tomoiu A, Gravel A, Flamand L. 2006. Mapping of human herpesvirus 6 immediate-early 2 protein transactivation domains. Virology 354:91-102. http://dx.doi.org/10.1016/j.virol.2006.06.030.
59. Chen M, Popescu N, Woodworth C, Berneman Z, Corbellino M, Lusso P, Ablashi DV, DiPaolo JA. 1994. Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression. J Virol 68:1173-1178.
60. Rotola A, Ravaioli T, Gonelli A, Dewhurst S, Cassai E, Di Luca D. 1998. U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc Natl Acad SciUSA95:13911- 13916. http://dx.doi.org/10.1073/pnas.95.23.13911.
61. Kondo K, Shimada K, Sashihara J, Tanaka-Taya K, Yamanishi K. 2002. Identification of human herpesvirus 6 latency-associated transcripts. J Virol 76:4145-4151. http://dx.doi.org/10.1128/JVI.76.8.4145-4151.2002.
62. Daibata M, Taguchi T, Taguchi H, Miyoshi I. 1998. Integration of human herpesvirus 6 in a Burkitt's lymphoma cell line. Br J Haematol 102:1307-1313. http://dx.doi.org/10.1046/j.1365-2141.1998.00903.x.
63. Luppi M, Barozzi P, Marasca R, Torelli G. 1994. Integration of human herpesvirus-6 (HHV-6) genome in chromosome 17 in two lymphoma patients. Leukemia 8(Suppl 1):S41-S45.
64. Daibata M, Taguchi T, Nemoto Y, Taguchi H, Miyoshi I. 1999. Inheritance of chromosomally integrated human herpesvirus 6 DNA. Blood 94:1545-1549.
65. Clark DA, Nacheva EP, Leong HN, Brazma D, Li YT, Tsao EH, Buyck HC, Atkinson CE, Lawson HM, Potter MN, Griffiths PD. 2006. Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. J Infect Dis 193:912-916. http://dx.doi.org/10.1086/500838.
66. Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR. 2012. Chromosomally inte- grated human herpesvirus 6: questions and answers. Rev Med Virol 22: 144-155. http://dx.doi.org/10.1002/rmv.715.
67. Godet AN, Soignon G, Koubi H, Bonnafous P, Agut H, Poirot C, Gautheret-Dejean A. 20 May 2014. Presence of HHV-6 genome in spermatozoa in a context of couples with low fertility: what type of infection? Andrologia http://dx.doi.org/10.1111/and.12299.
68. Michou V, Liarmakopoulou S, Thomas D, Tsimaratou K, Makarounis K, Constantoulakis P, Angelopoulou R, Tsilivakos V. 2012. Herpes virus infected spermatozoa following density gradient centrifugation for IVF purposes. Andrologia 44:174-180. http://dx.doi.org/10.1111/j.1439 -0272.2010.01121.x.
69. Endo A, Watanabe K, Ohye T, Suzuki K, Matsubara T, Shimizu N, Kurahashi H, Yoshikawa T, Katano H, Inoue N, Imai K, Takagi M, Morio T, Mizutani S. 2014. Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency. Clin Infect Dis 59:545-548. http://dx.doi.org/10.1093/cid/ciu323.
70. Thomson BJ, Efstathiou S, Honess RW. 1991. Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6. Nature 351:78-80. http://dx.doi.org/10.1038/351078a0.
71. Flamand L, Romerio F, Reitz MS, Gallo RC. 1998. CD4 promoter transactivation by human herpesvirus 6. J Virol 72:8797-8805.
72. Gravel A, Tomoiu A, Cloutier N, Gosselin J, Flamand L. 2003. Characterization of the immediate-early 2 protein of human herpesvirus 6, a promiscuous transcriptional activator. Virology 308:340-353. http://dx .doi.org/10.1016/S0042-6822(03)00007-2.
73. Kashanchi F, Araujo J, Doniger J, Muralidhar S, Hoch R, Khleif S, Mendelson E, Thompson J, Azumi N, Brady JN, Luppi M, Torelli G, Rosenthal LJ. 1997. Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene 14:359-367. http://dx.doi.org/10.1038/sj.onc.1200840.
74. Mori Y, Dhepakson P, Shimamoto T, Ueda K, Gomi Y, Tani H, Matsuura Y, Yamanishi K. 2000. Expression of human herpesvirus 6B rep within infected cells and binding of its gene product to the TATAbinding protein in vitro and in vivo. J Virol 74:6096-6104. http://dx.doi .org/10.1128/JVI.74.13.6096-6104.2000.
75. Caruso A, Caselli E, Fiorentini S, Rotola A, Prandini A, Garrafa E, Saba E, Alessandri G, Cassai E, Di Luca D. 2009. U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis. Proc Natl Acad Sci U S A 106:20446-20451. http://dx.doi.org/10.1073/pnas .0905535106.
76. Yeo WM, Isegawa Y, Chow VT. 2008. The U95 protein of human herpesvirus 6B interacts with human GRIM-19: silencing of U95 expression reduces viral load and abrogates loss of mitochondrial membrane potential. J Virol 82:1011-1020. http://dx.doi.org/10.1128/JVI.01156-07.
77. Gautheret-Dejean A, Agut H. 2014. Practical diagnostic procedures for HHV-6A, HHV-6B, and HHV-7, p 9-34. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
78. Tesini BL, Epstein LG, Caserta MT. 2014. Clinical impact of primary infection with roseoloviruses. Curr Opin Virol 9:91-96. http://dx.doi.org /10.1016/j.coviro.2014.09.013.
79. Aubin JT, Poirel L, Agut H, Huraux JM, Bignozzi C, Brossard Y, Mulliez N, Roume J, Lecuru F, Taurelle R. 1992. Intrauterine transmission of human herpesvirus 6. Lancet 340:482-483. http://dx.doi.org /10.1016/0140-6736(92)91801-E.
80. Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, Knott A, Dewhurst S, Insel RA, Epstein LG. 1994. Human herpesvirus- 6 infection in children. A prospective study of complications and reactivation. N Engl J Med 331:432-438.
81. Mendel I, de Matteis M, Bertin C, Delaporte B, Maguer D, Collandre H, Buffet-Janvresse C. 1995. Fulminant hepatitis in neonates with human herpesvirus 6 infection. Pediatr Infect Dis J 14:993-997. http://dx .doi.org/10.1097/00006454-199511000-00013.
82. Hall CB, Caserta MT, Schnabel KC, Boettrich C, McDermott MP, Lofthus GK, Carnahan JA, Dewhurst S. 2004. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 145:472-477. http://dx.doi.org/10.1016/j.jpeds.2004.06.017.
83. Akashi K, Eizuru Y, Sumiyoshi Y, Minematsu T, Hara S, Harada M, Kikuchi M, Niho Y, Minamishima Y. 1993. Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 329:168-171. http://dx.doi.org/10 .1056/NEJM199307153290304.
84. Ward KN, Gray JJ, Efstathiou S. 1989. Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 28:69-72. http://dx.doi.org/10.1002 /jmv.1890280203.
85. Kusuhara K, Takabayashi A, Ueda K, Hidaka Y, Minamishima I, Take H, Fujioka K, Imai S, Osato T. 1997. Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic virus type I in Japan. Microbiol Immunol 41:309-312. http://dx.doi.org/10.1111/j.1348-0421.1997.tb01206.x.
86. Fillet AM, Raphael M, Visse B, Audouin J, Poirel L, Agut H. 1995. Controlled study of human herpesvirus 6 detection in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma. The French Study Group for HIV-Associated Tumors. J Med Virol 45:106-112.
87. Cone RW, Huang ML, Hackman RC, Corey L. 1996. Coinfection with human herpesvirus 6 variants A and B in lung tissue. J Clin Microbiol 34:877-881.
88. Lacoste V, Verschoor EJ, Nerrienet E, Gessain A. 2005. A novel homologue of human herpesvirus 6 in chimpanzees. J Gen Virol 86:2135-2140. http://dx.doi.org/10.1099/vir.0.81034-0.
89. Staheli JP, Dyen MR, Lewis P, Barcy S. 2014. Discovery and biological characterization of two novel pig-tailed macaque homologs of HHV-6 and HHV-7. Virology 471-473:126-140. http://dx.doi.org/10.1016/j .virol.2014.10.008.
90. Reynaud JM, Horvat B. 2013. Animal models for human herpesvirus 6 infection. Front Microbiol 4:174. http://dx.doi.org/10.3389/fmicb.2013 .00174.
91. Leibovitch E, Wohler JE, Cummings Macri SM, Motanic K, Harberts E, Gaitan MI, Maggi P, Ellis M, Westmoreland S, Silva A, Reich DS, Jacobson S. 2013. Novel marmoset (Callithrix jacchus) model of human herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization. PLoS Pathog 9:e1003138. http://dx.doi.org/10.1371 /journal.ppat.1003138.
92. Krueger G, Lautenschlager I. 2014. Pathologic features of HHV-6A, HHV-6B, and HHV-7 infection (light and electron microscopy), p 35-67. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
93. Harberts E, Yao K, Wohler JE, Maric D, Ohayon J, Henkin R, Jacobson S. 2011. Human herpesvirus-6 entry into the central nervous system through the olfactory pathway. Proc Natl Acad Sci U S A 108: 13734-13739. http://dx.doi.org/10.1073/pnas.1105143108.
94. Gautheret-Dejean A, Dejean O, Vastel L, Kerboull M, Aubin JT, Franti M, Agut H. 2000. Human herpesvirus-6 and human herpesvirus-7 in the bone marrow from healthy subjects. Transplantation 69:1722-1723.
95. Kondo K, Sashihara J, Shimada K, Takemoto M, Amo K, Miyagawa H, Yamanishi K. 2003. Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6. J Virol 77:2258-2264. http://dx.doi.org /10.1128/JVI.77.3.2258-2264.2003.
96. Katsafanas GC, Schirmer EC, Wyatt LS, Frenkel N. 1996. In vitro activation of human herpesviruses 6 and 7 from latency. Proc Natl Acad Sci U S A 93:9788-9792. http://dx.doi.org/10.1073/pnas.93.18.9788.
97. Saxinger C, Polesky H, Eby N, Grufferman S, Murphy R, Tegtmeir G, Parekh V, Memon S, Hung C. 1988. Antibody reactivity with HBLV (HHV-6) in U.S. populations. J Virol Methods 21:199-208. http://dx.doi .org/10.1016/0166-0934(88)90066-3.
98. Calvo-Calle JM, Stern LJ. 2014. The immune response to HHV-6, p 235-249. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
99. Becerra A, Gibson L, Stern LJ, Calvo-Calle JM. 2014. Immune response to HHV-6 and implications for immunotherapy. Curr Opin Virol 9:154-161. http://dx.doi.org/10.1016/j.coviro.2014.10.001.
100. Gerdemann U, Keukens L, Keirnan JM, Katari UL, Nguyen CT, de Pagter AP, Ramos CA, Kennedy-Nasser A, Gottschalk SM, Heslop HE, Brenner MK, Rooney CM, Leen AM. 2013. Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation. Blood 121:207-218. http://dx.doi.org/10 .1182/blood-2012-05-430413.
101. Nastke MD, Becerra A, Yin L, Dominguez-Amorocho O, Gibson L, Stern LJ, Calvo-Calle JM. 2012. Human CD4+ T cell response to human herpesvirus 6. J Virol 86:4776-4792. http://dx.doi.org/10.1128/JVI .06573-11.
102. Martin LK, Schub A, Dillinger S, Moosmann A. 2012. Specific CD8(+) T cells recognize human herpesvirus 6B. Eur J Immunol 42:2901-2912. http://dx.doi.org/10.1002/eji.201242439.
103. Flamand L, Stefanescu I, Menezes J. 1996. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 97:1373-1381. http://dx.doi.org/10.1172/JCI118557.
104. Flamand L, Gosselin J, D'Addario M, Hiscott J, Ablashi DV, Gallo RC, Menezes J. 1991. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 65:5105-5110.
105. Dewin DR, Catusse J, Gompels UA. 2006. Identification and characterization of U83A viral chemokine, a broad and potent beta-chemokine agonist for human CCRs with unique selectivity and inhibition by spliced isoform. J Immunol 176:544-556. http://dx.doi.org/10.4049/jimmunol .176.1.544.
106. Catusse J, Spinks J, Mattick C, Dyer A, Laing K, Fitzsimons C, Smit MJ, Gompels UA. 2008. Immunomodulation by herpesvirus U51A chemokine receptor via CCL5 and FOG-2 down-regulation plus XCR1 and CCR7 mimicry in human leukocytes. Eur J Immunol 38:763-777. http://dx.doi.org/10.1002/eji.200737618.
107. Lusso P, Gallo RC. 1995. Human herpesvirus 6 in AIDS. Immunol Today 16:67-71. http://dx.doi.org/10.1016/0167-5699(95)80090-5.
108. Flamand L, Menezes J. 1996. Cyclic AMP-responsive elementdependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6. J Virol 70:1784-1791.
109. Tai AK, Luka J, Ablashi D, Huber BT. 2009. HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol 46:47-48. http://dx.doi.org/10.1016/j.jcv.2009.05.019.
110. Gautheret-Dejean A, Agut H. 2014. Practical diagnostic procedures for HHV-A, HHV-6B, and HHV-7, p 9-34. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
111. Descamps V, Avenel-Audran M, Valeyrie-Allanore L, Bensaid B, Barbaud A, Al Jawhari M, Ranger-Rogez S. 2013. Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS). JAMA Dermatol 149:565-569. http://dx.doi.org/10.1001 /jamadermatol.2013.2018.
112. Asada H, Yalcin S, Balachandra K, Higashi K, Yamanishi K. 1989. Establishment of titration system for human herpesvirus 6 and evaluation of neutralizing antibody response to the virus. J Clin Microbiol 27:2204-2207.
113. Chou SW, Scott KM. 1990. Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant recipients with primary cytomegalovirus infection. J Clin Microbiol 28:851-854.
114. LaCroix S, Stewart JA, Thouless ME, Black JB. 2000. An immunoblot assay for detection of immunoglobulin M antibody to human herpesvirus 6. Clin Diagn Lab Immunol 7:823-827. http://dx.doi.org/10.1128 /CDLI.7.5.823-827.2000.
115. Ward KN, Gray JJ, Joslin ME, Sheldon MJ. 1993. Avidity of IgG antibodies to human herpesvirus-6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross-reactivity with other herpesviruses. J Med Virol 39:44-49. http://dx.doi.org/10 .1002/jmv.1890390109.
116. Sutherland S, Christofinis G, O'Grady J, Williams R. 1991. A serological investigation of human herpesvirus 6 infections in liver transplant recipients and the detection of cross-reacting antibodies to cytomegalovirus. J Med Virol 33:172-176. http://dx.doi.org/10.1002 /jmv.1890330306.
117. Lautenschlager I, Hockerstedt K, Linnavuori K, Taskinen E. 1998. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 26:702-707. http://dx.doi.org/10.1086/514592.
118. Loginov R, Karlsson T, Hockerstedt K, Ablashi D, Lautenschlager I. 2010. Quantitative HHV-6B antigenemia test for the monitoring of transplant patients. Eur J Clin Microbiol Infect Dis 29:881-886. http://dx .doi.org/10.1007/s10096-010-0923-1.
119. Flamand L, Gravel A, Boutolleau D, Alvarez-Lafuente R, Jacobson S, Malnati MS, Kohn D, Tang YW, Yoshikawa T, Ablashi D. 2008. Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum. J Clin Microbiol 46:2700-2706. http://dx.doi.org /10.1128/JCM.00370-08.
120. Caserta MT, Hall CB, Schnabel K, Lofthus G, Marino A, Shelley L, Yoo C, Carnahan J, Anderson L, Wang H. 2010. Diagnostic assays for active infection with human herpesvirus 6 (HHV-6). J Clin Virol 48:55-57. http://dx.doi.org/10.1016/j.jcv.2010.02.007.
121. Boutolleau D, Duros C, Bonnafous P, Caiola D, Karras A, Castro ND, Ouachee M, Narcy P, Gueudin M, Agut H, Gautheret-Dejean A. 2006. Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J Clin Virol 35:257-263. http://dx.doi.org/10.1016/j.jcv.2005.08.002.
122. Razonable RR, Hayden RT. 2013. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev 26:703-727. http://dx.doi.org/10 .1128/CMR.00015-13.
123. Bonnafous P, Naesens L, Petrella S, Gautheret-Dejean A, Boutolleau D, Sougakoff W, Agut H. 2007. Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet. Antivir Ther 12: 877-888.
124. Isegawa Y, Matsumoto C, Nishinaka K, Nakano K, Tanaka T, Sugimoto N, Ohshima A. 2010. PCR with quenching probes enables the rapid detection and identification of ganciclovir-resistance-causing U69 gene mutations in human herpesvirus 6. Mol Cell Probes 24:167-177. http://dx.doi.org/10.1016/j.mcp.2010.01.002.
125. Leibovitch EC, Brunetto GS, Caruso B, Fenton K, Ohayon J, Reich DS, Jacobson S. 2014. Coinfection of human herpesviruses 6A (HHV-6A) and HHV-6B as demonstrated by novel digital droplet PCR assay. PLoS One 9:e92328. http://dx.doi.org/10.1371/journal.pone.0092328.
126. Sedlak RH, Cook L, Huang ML, Magaret A, Zerr DM, Boeckh M, Jerome KR. 2014. Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. Clin Chem 60:765-772. http://dx .doi.org/10.1373/clinchem.2013.217240.
127. Tuddenham L, Jung JS, Chane-Woon-Ming B, Dolken L, Pfeffer S. 2012. Small RNA deep sequencing identifies microRNAs and other small noncoding RNAs from human herpesvirus 6B. J Virol 86:1638-1649. http://dx.doi.org/10.1128/JVI.05911-11.
128. Achour A, Boutolleau D, Gautheret-Dejean A, Agut H. 2006. Is human herpesvirus-6 DNA in plasma the right marker for active infection? J Infect Dis 194:1795-1796. http://dx.doi.org/10.1086/509624.
129. Boutolleau D, Fernandez C, Andre E, Imbert-Marcille BM, Milpied N, Agut H, Gautheret-Dejean A. 2003. Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 187:179-186. http://dx .doi.org/10.1086/367677.
130. Ljungman P, Wang FZ, Clark DA, Emery VC, Remberger M, Ringden O, Linde A. 2000. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 111:774-781. http://dx.doi.org/10.1111/j.1365-2141.2000.02422.x.
131. Gautheret-Dejean A, Manichanh C, Thien-Ah-Koon F, Fillet AM, Mangeney N, Vidaud M, Dhedin N, Vernant JP, Agut H. 2002. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods 100:27-35. http://dx.doi.org/10 .1016/S0166-0934(01)00390-1.
132. Ward KN, Leong HN, Nacheva EP, Howard J, Atkinson CE, Davies NW, Griffiths PD, Clark DA. 2006. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol 44:1571-1574. http://dx.doi.org/10.1128/JCM.44.4.1571-1574.2006.
133. Gautheret-Dejean A, Henquell C, Mousnier F, Boutolleau D, Bonnafous P, Dhedin N, Settegrana C, Agut H. 2009. Different expression of human herpesvirus-6 (HHV-6) load in whole blood may have a significant impact on the diagnosis of active infection. J Clin Virol 46:33-36. http://dx.doi.org/10.1016/j.jcv.2009.05.020.
134. Hill JA, Sedlak RH, Jerome KR. 2014. Past, present, and future perspectives on the diagnosis of Roseolovirus infections. Curr Opin Virol 9C: 84-90. http://dx.doi.org/10.1016/j.coviro.2014.09.014.
135. Ogata M. 2009. Human herpesvirus 6 in hematological malignancies. J Clin Exp Hematop 49:57-67. http://dx.doi.org/10.3960/jslrt.49.57.
136. Yao K, Honarmand S, Espinosa A, Akhyani N, Glaser C, Jacobson S. 2009. Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis. Ann Neurol 65:257-267. http://dx.doi.org/10 .1002/ana.21611.
137. Caserta MT, Dewhurst S. 2011. Dazed and confused by HHV-6. Blood 117:5016-5018. http://dx.doi.org/10.1182/blood-2011-03-342741.
138. Kawamura Y, Sugata K, Ihira M, Mihara T, Mutoh T, Asano Y, Yoshikawa T. 2011. Different characteristics of human herpesvirus 6 encephalitis between primary infection and viral reactivation. J Clin Virol 51:12-19. http://dx.doi.org/10.1016/j.jcv.2011.02.002.
139. Ward KN, Leong HN, Thiruchelvam AD, Atkinson CE, Clark DA. 2007. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 45:1298-1304. http://dx.doi.org/10.1128/JCM.02115-06.
140. Alenda R, Alvarez-Lafuente R, Costa-Frossard L, Arroyo R, Mirete S, Alvarez-Cermeno JC, Villar LM. 2014. Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis. Eur J Neurol 21:1096-1101. http://dx.doi.org/10.1111/ene.12435.
141. Caselli E, Boni M, Bracci A, Rotola A, Cermelli C, Castellazzi M, Di Luca D, Cassai E. 2002. Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis. J Clin Microbiol 40:4131-4137. http://dx.doi.org/10.1128/JCM.40.11 .4131-4137.2002.
142. Crawford JR. 2014. HHV-6A and HHV-6B in cancer, p 297-310. In Flamand L, Lautenschlager I, Krueger G, AblashiD(ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
143. Lacroix A, Collot-Teixeira S, Mardivirin L, Jaccard A, Petit B, Piguet C, Sturtz F, Preux PM, Bordessoule D, Ranger-Rogez S. 2010. Involvement of human herpesvirus-6 variant B in classic Hodgkin's lymphoma via DR7 oncoprotein. Clin Cancer Res 16:4711-4721. http://dx.doi.org /10.1158/1078-0432.CCR-10-0470.
144. Cuomo L, Trivedi P, de Grazia U, Calogero A, D'Onofrio M, Yang W, Frati L, Faggioni A, Rymo L, Ragona G. 1998. Upregulation of Epstein- Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells. J Med Virol 55:219 -226. http://dx.doi.org/10.1002/(SICI)1096-9071(199807)55 :3_219::AID-JMV7 3.0.CO;2-4.
145. Lu C, Zeng Y, Huang Z, Huang L, Qian C, Tang G, Qin D. 2005. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma- associated herpesvirus. Am J Pathol 166:173-183. http://dx.doi.org /10.1016/S0002-9440(10)62242-0.
146. Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ. 2003. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 53:189-197. http://dx.doi.org/10.1002 /ana.10425.
147. Soldan SS, Fogdell-Hahn A, Brennan MB, Mittleman BB, Ballerini C, Massacesi L, Seya T, McFarland HF, Jacobson S. 2001. Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Ann Neurol 50:486-493. http://dx.doi.org/10.1002/ana.1135.
148. Caselli E, Zatelli MC, Rizzo R, Benedetti S, Martorelli D, Trasforini G, Cassai E, degli Uberti EC, Di Luca D, Dolcetti R. 2012. Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis. PLoS Pathog 8:e1002951. http://dx.doi.org/10 .1371/journal.ppat.1002951.
149. Reddy S, Manna P. 2005. Quantitative detection and differentiation of human herpesvirus 6 subtypes in bone marrow transplant patients by using a single real-time polymerase chain reaction assay. Biol Blood Marrow Transplant 11:530-541. http://dx.doi.org/10.1016/j.bbmt.2005.04 .010.
150. Clark DA, Griffiths PD. 2003. Human herpesvirus 6: relevance of infection in the immunocompromised host. Br J Haematol 120:384-395. http://dx.doi.org/10.1046/j.1365-2141.2003.04048.x.
151. Caserta MT, McDermott MP, Dewhurst S, Schnabel K, Carnahan JA, Gilbert L, Lathan G, Lofthus GK, Hall CB. 2004. Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children. J Pediatr 145:478-484. http://dx.doi.org/10.1016/j.jpeds.2004.06.016.
152. Collot S, Petit B, Bordessoule D, Alain S, Touati M, Denis F, Ranger- Rogez S. 2002. Real-time PCR for quantification of human herpesvirus 6 DNA from lymph nodes and saliva. J Clin Microbiol 40:2445-2451. http: //dx.doi.org/10.1128/JCM.40.7.2445-2451.2002.
153. Descamps V, Tohyama M, Shiohara T. 2014. HHV-6A and HHV-6B in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms, p 179-200. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
154. Hall CB, Caserta MT, Schnabel KC, McDermott MP, Lofthus GK, Carnahan JA, Gilbert LM, Dewhurst S. 2006. Characteristics and acquisition of human herpesvirus (HHV) 7 infections in relation to infection with HHV-6. J Infect Dis 193:1063-1069. http://dx.doi.org/10.1086 /503434.
155. Bates M, Monze M, Bima H, Kapambwe M, Clark D, Kasolo FC, Gompels UA. 2009. Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of sub-Saharan Africa. J Med Virol 81:779-789. http://dx.doi.org/10.1002/jmv.21455.
156. Tembo J, Kabwe M, Chilukutu L, Chilufya M, Mwaanza N, Chabala C, Zumla A, Bates M. 2015. Prevalence and risk factors for betaherpesvirus DNAemia in children 3 weeks and +2 years of age admitted to a large referral hospital in sub-Saharan Africa. Clin Infect Dis 60:423-431. http: //dx.doi.org/10.1093/cid/ciu853.
157. Yoshikawa T, Ohashi M, Miyake F, Fujita A, Usui C, Sugata K, Suga S, Hashimoto S, Asano Y. 2009. Exanthem subitum-associated encephalitis: nationwide survey in Japan. Pediatr Neurol 41:353-358. http://dx .doi.org/10.1016/j.pediatrneurol.2009.05.012.
158. Al-Zubeidi D, Thangarajh M, Pathak S, Cai C, Schlaggar BL, Storch GA, Grange DK, Watson ME, Jr. 2014. Fatal human herpesvirus 6-associated encephalitis in two boys with underlying POLG mitochondrial disorders. Pediatr Neurol 51:448 - 452. http://dx.doi.org /10.1016/j.pediatrneurol.2014.04.006.
159. Epstein LG, Shinnar S, Hesdorffer DC, Nordli DR, Hamidullah A, Benn EK, Pellock JM, Frank LM, Lewis DV, Moshe SL, Shinnar RC, Sun S. 2012. Human herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study. Epilepsia 53:1481-1488. http://dx.doi.org/10.1111/j .1528-1167.2012.03542.x.
160. Flamand L, Lautenschlager I, Krueger G, Ablashi D. 2014. Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
161. Caserta MT, Hall CB, Canfield RL, Davidson P, Lofthus G, Schnabel K, Carnahan J, Shelley L, Wang H. 2014. Early developmental outcomes of children with congenital HHV-6 infection. Pediatrics 134: 1111-1118. http://dx.doi.org/10.1542/peds.2014-0886.
162. Hall CB, Caserta MT, Schnabel K, Shelley LM, Marino AS, Carnahan JA, Yoo C, Lofthus GK, McDermott MP. 2008. Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection. Pediatrics 122:513-520. http://dx.doi.org/10 .1542/peds.2007-2838.
163. Hall CB, Caserta MT, Schnabel KC, Shelley LM, Carnahan JA, Marino AS, Yoo C, Lofthus GK. 2010. Transplacental congenital human herpesvirus 6 infection caused by maternal chromosomally integrated virus. J Infect Dis 201:505-507. http://dx.doi.org/10.1086/650495.
164. Razonable RR. 2010. Infections due to human herpesvirus 6 in solid organ transplant recipients. Curr Opin Organ Transplant 15:671-675. http://dx.doi.org/10.1097/MOT.0b013e3283404325.
165. Razonable RR, Lautenschlager I. 2010. Impact of human herpesvirus 6 in liver transplantation. World J Hepatol 2:345-353. http://dx.doi.org/10 .4254/wjh.v2.i9.345.
166. Jeulin H, Agrinier N, Guery M, Salmon A, Clement L, Bordigoni P, Venard V. 2013. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation. Transplantation 95:1292-1298. http://dx.doi.org /10.1097/TP.0b013e318289958b.
167. Zerr DM, Fann JR, Breiger D, Boeckh M, Adler AL, Xie H, Delaney C, Huang ML, Corey L, Leisenring WM. 2011. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 117:5243-5249. http://dx.doi.org/10.1182 /blood-2010-10-316083.
168. Caiola D, Karras A, Flandre P, Boutolleau D, Scieux C, Agut H, Legendre C, Gautheret-Dejean A. 2012. Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation. J Med Virol 84:450-456. http://dx.doi.org/10.1002/jmv.23206.
169. Humar A, Malkan G, Moussa G, Greig P, Levy G, Mazzulli T. 2000. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 181:1450-1453. http://dx.doi.org /10.1086/315391.
170. Corbellino M, Lusso P, Gallo RC, Parravicini C, Galli M, Moroni M. 1993. Disseminated human herpesvirus 6 infection in AIDS. Lancet 342: 1242.
171. Gautheret A, Aubin JT, Fauveau V, Rozenbaum W, Huraux JM, Agut H. 1995. Rate of detection of human herpesvirus-6 at different stages of HIV infection. Eur J Clin Microbiol Infect Dis 14:820-824. http://dx.doi .org/10.1007/BF01691003.
172. Lusso P, Gallo RC. 1994. Human herpesvirus 6 in AIDS. Lancet 343: 555-556. http://dx.doi.org/10.1016/S0140-6736(94)91515-6.
173. Spira TJ, Bozeman LH, Sanderlin KC, Warfield DT, Feorino PM, Holman RC, Kaplan JE, Fishbein DB, Lopez C. 1990. Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection. J Infect Dis 161:567-570. http://dx .doi.org/10.1093/infdis/161.3.567.
174. Knox KK, Harrington DP, Carrigan DR. 1995. Fulminant human herpesvirus six encephalitis in a human immunodeficiency virusinfected infant. J Med Virol 45:288-292. http://dx.doi.org/10.1002/jmv .1890450309.
175. Fillet AM, Reux I, Joberty C, Fournier JG, Hauw JJ, Le Hoang P, Bricaire F, Huraux JM, Agut H. 1996. Detection of human herpes virus 6 in AIDS-associated retinitis by means of in situ hybridization, polymerase chain reaction and immunohistochemistry. J Med Virol 49:289-295.
176. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, Saraux JL, Grange MJ, Grossin M, Navratil E, Crickx B, Belaich S. 1997. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 137:605- 608. http://dx.doi.org/10 .1111/j.1365-2133.1997.tb03795.x.
177. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, Hashimoto K. 1998. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134:1113-1117.
178. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. 2007. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156:1083-1084. http://dx.doi.org/10.1111/j.1365-2133.2007.07807.x.
179. Yoshikawa K. 2014. HHV-6B and HHV-7 in exanthema subitum and related skin diseases, p 153-166. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
180. Picard D, Janela B, Descamps V, D'Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J, Joly P, Musette P. 2010. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2:46ra62. http://dx.doi.org/10.1126/scitranslmed.3001116.
181. Mardivirin L, Descamps V, Lacroix A, Delebassee S, Ranger-Rogez S. 2009. Early effects of drugs responsible for DRESS on HHV-6 replication in vitro. J Clin Virol 46:300-302. http://dx.doi.org/10.1016/j.jcv.2009.08 .006.
182. Mardivirin L, Valeyrie-Allanore L, Branlant-Redon E, Beneton N, Jidar K, Barbaud A, Crickx B, Ranger-Rogez S, Descamps V. 2010. Amoxicillin-induced flare in patients with DRESS (drug reaction with eosinophilia and systemic symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on human herpesvirus 6 replication in vitro. Eur J Dermatol 20:68-73. http://dx.doi.org/10.1684/ejd .2010.0821.
183. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinski RC, Brown JP, Burmer GC. 1995. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92:7440-7444. http://dx.doi.org/10.1073/pnas.92.16.7440.
184. Leibovitch EC, Jacobson S. 2014. Evidence linking HHV-6 with multiple sclerosis: an update. Curr Opin Virol 9:127-133. http://dx.doi.org/10 .1016/j.coviro.2014.09.016.
185. Merelli E, Bedin R, Sola P, Barozzi P, Mancardi GL, Ficarra G, Franchini G. 1997.Humanherpes virus 6 andhumanherpes virus 8DNAsequences in brains of multiple sclerosis patients, normal adults and children. J Neurol 244:450-454. http://dx.doi.org/10.1007/s004150050121.
186. Liedtke W, Malessa R, Faustmann PM, Eis-Hubinger AM. 1995. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1:253-258. http://dx.doi.org/10.3109/13550289509114021.
187. Cermelli C, Berti R, Soldan SS, Mayne M, D'Ambrosia MJ, Ludwin SK, Jacobson S. 2003. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 187:1377-1387. http://dx.doi.org/10.1086/368166.
188. Virtanen JO, Pietilainen-Nicklen J, Uotila L, Farkkila M, Vaheri A, Koskiniemi M. 2011. Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid. J Neuroimmunol 237:93-97. http: //dx.doi.org/10.1016/j.jneuroim.2011.06.012.
189. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U. 2006. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581-1590. http://dx .doi.org/10.1161/CIRCULATIONAHA.105.606509.
190. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP. 2005. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965-1970. http: //dx.doi.org/10.1161/CIRCULATIONAHA.105.548156.
191. Leveque N, Boulagnon C, Brasselet C, Lesaffre F, Boutolleau D, Metz D, Fornes P, Andreoletti L. 2011. A fatal case of human herpesvirus 6 chronic myocarditis in an immunocompetent adult. J Clin Virol 52:142-145. http://dx.doi.org/10.1016/j.jcv.2011.06.017.
192. Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Takemoto Y, Okamoto T, Kanamaru A, Kakishita E. 2003. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant 31:475-479. http://dx.doi.org/10.1038/sj.bmt.1703879.
193. Zerr DM, Komaroff AL. 2014. Cognitive dysfunction from HHV-6A and HHV-B, p 99-122. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
194. Buchwald D, Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A, Ablashi DV, Salahuddin SZ, Saxinger C, Biddle R, Kikinis R, Jolesz FA, Folks T, Balachandran N, Peter JB, Gallo RC, Komaroff AL. 1992. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 116:103-113. http://dx.doi.org/10.7326/0003-4819-116-2-103.
195. Patnaik M, Komaroff AL, Conley E, Ojo-Amaize EA, Peter JB. 1995. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/ 38) in patients with chronic fatigue syndrome. J Infect Dis 172:1364-1367. http://dx.doi.org/10.1093/infdis/172.5.1364.
196. Ablashi DV, Zompetta C, Lease C, Josephs SF, Balachandra N, Komaroff AL, Krueger GR, Henry B, Lukau J, Salahuddin SZ. 1991. Human herpesvirus 6 (HHV6) and chronic fatigue syndrome (CFS). Can Dis Wkly Rep 17(Suppl 1E):33-40.
197. Lacroix A, Jaccard A, Rouzioux C, Piguet C, Petit B, Bordessoule D, Ranger-Rogez S. 2007. HHV-6 and EBV DNA quantitation in lymph nodes of 86 patients with Hodgkin's lymphoma. J Med Virol 79:1349-1356. http://dx.doi.org/10.1002/jmv.20868.
198. Bell AJ, Gallagher A, Mottram T, Lake A, Kane EV, Lightfoot T, Roman E, Jarrett RF. 2014. Germ-line transmitted, chromosomally integrated HHV-6 and classical Hodgkin lymphoma. PLoS One 9:e112642. http://dx.doi.org/10.1371/journal.pone.0112642.
199. Luppi M, Marasca R, Barozzi P, Artusi T, Torelli G. 1993. Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy- like lymphoma. Leuk Res 17:1003-1011. http://dx.doi.org/10.1016 /0145-2126(93)90049-Q.
200. Zhou Y, Attygalle AD, Chuang SS, Diss T, Ye H, Liu H, Hamoudi RA, Munson P, Bacon CM, Dogan A, Du MQ. 2007. Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load. Br J Haematol 138:44-53. http://dx.doi.org/10.1111 /j.1365-2141.2007.06620.x.
201. Agut H, Collandre H, Aubin JT, Guetard D, Favier V, Ingrand D, Montagnier L, Huraux JM. 1989. In vitro sensitivity of human herpesvirus- 6 to antiviral drugs. Res Virol 140:219-228. http://dx.doi.org/10 .1016/S0923-2516(89)80099-8.
202. Agut H, Aubin JT, Huraux JM. 1991. Homogeneous susceptibility of distinct human herpesvirus 6 strains to antivirals in vitro. J Infect Dis 163:1382-1383. http://dx.doi.org/10.1093/infdis/163.6.1382.
203. Pritchett JC, Naesens L, Montoya JG. 2014. Treating HHV-6 infections- the laboratory efficacy and clinical use of anti-HHV-6 agents, p 311-331. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
204. Prichard MN, Whitley RJ. 2014. The development of new therapies for human herpesvirus 6. Curr Opin Virol 9:148-153. http://dx.doi.org/10 .1016/j.coviro.2014.09.019.
205. Manichanh C, Olivier-Aubron C, Lagarde JP, Aubin JT, Bossi P, Gautheret-Dejean A, Huraux JM, Agut H. 2001. Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo. J Gen Virol 82: 2767-2776.
206. Bonnafous P, Boutolleau D, Naesens L, Deback C, Gautheret-Dejean A, Agut H. 2008. Characterization of a cidofovir-resistant HHV-6 mutant obtained by in vitro selection. Antiviral Res 77:237-240. http://dx .doi.org/10.1016/j.antiviral.2007.12.004.
207. Safronetz D, Petric M, Tellier R, Parvez B, Tipples GA. 2003. Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase. J Med Virol 71:434-439. http://dx.doi.org/10.1002/jmv.10510.
208. Isegawa Y, Hara J, Amo K, Osugi Y, Takemoto M, Yamanishi K, Fukunaga R, Shibata M, Ohshima A, Horiguchi Y, Sugimoto N. 2009. Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient. J Clin Virol 44:15-19. http://dx.doi.org/10.1016/j.jcv.2008.09 .002.
209. Naesens L, Bonnafous P, Agut H, De Clercq E. 2006. Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts. J Clin Virol 37(Suppl 1):S69 -S75. http: //dx.doi.org/10.1016/S1386-6532(06)70015-4.
210. Naesens L, Stephens CE, Andrei G, Loregian A, De Bolle L, Snoeck R, Sowell JW, De Clercq E. 2006. Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses. Antiviral Res 72:60-67. http://dx.doi.org/10.1016/j.antiviral.2006.03.013.
211. Bonnafous P, Bogaert S, Godet AN, Agut H. 2013. HDP-CDV as an alternative for treatment of human herpesvirus-6 infections. J Clin Virol 56:175-176. http://dx.doi.org/10.1016/j.jcv.2012.11.006.
212. Milbradt J, Auerochs S, Korn K, Marschall M. 2009. Sensitivity of human herpesvirus 6 and other human herpesviruses to the broadspectrum antiinfective drug artesunate. J Clin Virol 46:24-28. http://dx .doi.org/10.1016/j.jcv.2009.05.017.
213. Hakacova N, Klingel K, Kandolf R, Engdahl E, Fogdell-Hahn A, Higgins T. 2013. First therapeutic use of artesunate in treatment of human herpesvirus 6B myocarditis in a child. J Clin Virol 57:157-160. http://dx.doi.org/10.1016/j.jcv.2013.02.005.
214. Yao K, Hoest C, Rashti F, Schott TC, Jacobson S. 2009. Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZTlipid- PFA on human herpesvirus-6B infected cells. J Clin Virol 46:10-14. http://dx.doi.org/10.1016/j.jcv.2009.05.014.
215. Bonnafous P, Agut H. 2010. Activity of H2G on human herpesvirus-6B strains either sensitive or resistant to ganciclovir. J Clin Virol 48:153-154. http://dx.doi.org/10.1016/j.jcv.2010.03.019.
216. De Clercq E, Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J. 2001. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 11:381-395. http://dx.doi.org/10.1002/rmv.336.
217. Prichard MN, Williams JD, Komazin-Meredith G, Khan AR, Price NB, Jefferson GM, Harden EA, Hartline CB, Peet NP, Bowlin TL. 2013. Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses. Antimicrob Agents Chemother 57:3518-3527. http://dx.doi.org/10.1128/AAC.00429-13.
218. De Clercq E, Naesens L. 2006. In search of effective anti-HHV-6 agents. J Clin Virol 37(Suppl 1):S82-S86. http://dx.doi.org/10.1016 /S1386-6532(06)70017-8.
219. Komazin-Meredith G, Cardinale SC, Williams JD, Peet NP, Prichard MN, Bowlin TL. 2013. Human herpesvirus 6 U69 kinase phosphorylates the methylenecyclopropane nucleosides cyclopropavir, MBX 2168, and MBX 1616 to their monophosphates. Antimicrob Agents Chemother 57:5760-5762. http://dx.doi.org/10.1128/AAC.00978-13.
220. Reymen D, Naesens L, Balzarini J, Holy A, Dvorakova H, De Clercq E. 1995. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res 28:343-357. http://dx.doi.org/10 .1016/0166-3542(95)00058-5.
221. Neyts J, Naesens L, Ying C, De Bolle L, De Clercq E. 2001. Antiherpesvirus activity of (1=S,2=R)-9-[[1=,2=-bis(hydroxymethyl)-cycloprop- 1=-yl]methyl]guanine (A-5021) in vitro and in vivo. Antiviral Res 49:115-120. http://dx.doi.org/10.1016/S0166-3542(00)00144-3.
222. De Bolle L, Andrei G, Snoeck R, Zhang Y, Van Lommel A, Otto M, Bousseau A, Roy C, De Clercq E, Naesens L. 2004. Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423. Biochem Pharmacol 67:325-336. http://dx.doi.org/10.1016/j.bcp.2003.08.042.
223. Lautenschlager I, Razonable RR. 2014. HHV-6A and HHV-6B in solid organ transplantation, p 201-215. In Flamand L, Lautenschlager I, Krueger G, Ablashi D (ed), Human herpesviruses HHV-6A, HHV-6B & HHV-7, 3rd ed. Elsevier, Amsterdam, Netherlands.
224. Razonable RR, Zerr DM. 2009. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant 9(Suppl 4):S97-S100. http: //dx.doi.org/10.1111/j.1600-6143.2009.02899_1.x.
225. Rozenberg F, Deback C, Agut H. 2011. Herpes simplex encephalitis: from virus to therapy. Infect Disord Drug Targets 11:235-250. http://dx .doi.org/10.2174/187152611795768088.
226. Agut H, Boutolleau D, Deback C, Bonnafous P, Gautheret-Dejean A. 2009. Testing the susceptibility of human herpesviruses to antivirals. Future Microbiol 4:1111-1123. http://dx.doi.org/10.2217/fmb.09.83.
227. Theodore WH, Epstein L, Gaillard WD, Shinnar S, Wainwright MS, Jacobson S. 2008. Human herpes virus 6B: a possible role in epilepsy? Epilepsia 49:1828 -1837. http://dx.doi.org/10.1111/j.1528-1167.2008 .01699.x.